How TTR stabilizers work in managing ATTR-CM
The right treatment can improve quality of life and contribute to better outcomes for people living with ATTR-CM.
The right treatment can improve quality of life and contribute to better outcomes for people living with ATTR-CM.
Technological advances have made it easier to diagnose transthyretin amyloid cardiomyopathy (ATTR-CM) and to identify it earlier.
The presence of carpal tunnel syndrome could help facilitate earlier detection of transthyretin amyloid cardiomyopathy.
Early detection of ATTR-CM is important for better symptom and disease management, improved quality of life and better prognosis.
Cardiologists are experienced in diagnosing a variety of heart-related conditions, including ATTR-CM.
Symptoms of transthyretin amyloid cardiomyopathy (ATTR-CM) resemble those of other heart conditions, which may lead to misdiagnosis.
Transthyretin amyloid cardiomyopathy (ATTR-CM) has symptoms that resemble progressive congestive heart failure.
Symptoms and survival rates can differ considerably between the variants of ATTR-CM.
Protein misfolding refers to a protein that is structurally abnormal and unable to achieve its normal native state.
Early symptoms of ATTR-CM are also commonly associated with congestive heart failure and other heart diseases.